References
- S. Sharma, G. Orlowski, and W. Song, Btk regulates B cell receptor-mediated antigen processing and presentation by controlling actin cytoskeleton dynamics in B cells, J. Immunol. 182 (2009), pp. 329–339. doi:https://doi.org/10.4049/jimmunol.182.1.329.
- A.B. Satterthwaite and O.N. Witte, The role of Bruton’s tyrosine kinase in B-cell development and function: A genetic perspective, Immunol. Rev. 175 (2000), pp. 120–127. doi:https://doi.org/10.1111/j.1600-065X.2000.imr017504.x.
- S. Pal Singh, F. Dammeijer, and R.W. Hendriks, Role of Bruton’s tyrosine kinase in B cells and malignancies, Mol. Cancer 17 (2018), pp. 57. doi:https://doi.org/10.1186/s12943-018-0779-z.
- J. Xiao, S. Zhang, M. Luo, Y. Zou, Y. Zhang, and Y. Lai, Effective virtual screening strategy focusing on the identification of novel Bruton’s tyrosine kinase inhibitors, J. Mol. Graph. Model. 60 (2015), pp. 142–154. doi:https://doi.org/10.1016/j.jmgm.2015.05.005.
- N. Zheng, J. Pan, Q. Hao, Y. Li, and W. Zhou, Design, synthesis and biological evaluation of novel 3-substituted pyrazolopyrimidine derivatives as potent Bruton’s tyrosine kinase (BTK) inhibitors, Bioorg. Med. Chem. 26 (2018), pp. 2165–2172. doi:https://doi.org/10.1016/j.bmc.2018.03.017.
- R. Li, Y. Du, and J. Shen, Molecular modelling studies on cinnoline-based BTK inhibitors using docking and structure-based 3D-QSAR, SAR QSAR Environ. Res. 29 (2018), pp. 847–873. doi:https://doi.org/10.1080/1062936X.2018.1518927.
- D.J. Marcotte, Y.T. Liu, R.M. Arduini, C.A. Hession, K. Miatkowski, C.P. Wildes, P.F. Cullen, V. Hong, B.T. Hopkins, E. Mertsching, T.J. Jenkins, M.J. Romanowski, D.P. Baker, and L.F. Silvian, Structures of human Bruton’s tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases, Protein Sci. 19 (2010), pp. 429–439. doi:https://doi.org/10.1002/pro.321.
- A. Rowland, M. van Dyk, A.A. Mangoni, J.O. Miners, R.A. McKinnon, M.D. Wiese, A. Rowland, G. Kichenadasse, H. Gurney, and M.J. Sorich, Kinase inhibitor pharmacokinetics: Comprehensive summary and roadmap for addressing inter-individual variability in exposure, Expert Opin. Drug Metab. Toxicol. 13 (2017), pp. 31–49. doi:https://doi.org/10.1080/17425255.2016.1229303.
- S. Ahmadi, A QSPR study of association constants of macrocycles toward sodium cation, Macroheterocycles 5 (2012), pp. 23–31. doi:https://doi.org/10.6060/mhc2012.110734a.
- S. Ahmadi and E. Habibpour, Application of GA-MLR for QSAR modeling of the arylthioindole class of tubulin polymerization inhibitors as anticancer agents, Curr. Med. Chem. Anticancer Agents 17 (2017), pp. 552–565. doi:https://doi.org/10.2174/1871520616666160811162105.
- S. Ahmadi, M. Mehrabi, S. Rezaei, and N. Mardafkan, Structure-activity relationship of the radical scavenging activities of some natural antioxidants based on the graph of atomic orbitals, J. Mol. Stuct. 1191 (2019), pp. 165–174. doi:https://doi.org/10.1016/j.molstruc.2019.04.103.
- R. Ancuceanu, B. Tamba, C.S. Stoicescu, and M. Dinu, Use of QSAR global models and molecular docking for developing new inhibitors of c-src tyrosine kinase, Int. J. Mol. Sci. 21 (2019), pp. 19. doi:https://doi.org/10.3390/ijms21010019.
- N. Thuille, K. Siegmund, V. Klepsch, J. Schorgenhuber, S. Danklmaier, M. Leitges, and G. Baier, Loss-of-function phenotype of a PKCtheta(T219A) knockin mouse strain, Cell Commun. Signal 17 (2019), pp. 141. doi:https://doi.org/10.1186/s12964-019-0466-8.
- H. Yuan, Y. Wang, and Y. Cheng, Local and global quantitative structure−activity relationship modeling and prediction for the baseline toxicity, J. Chem. Inf. Model. 47 (2007), pp. 159–169. doi:https://doi.org/10.1021/ci600299j.
- A. Sosnowska, M. Grzonkowska, and T. Puzyn, Global versus local QSAR models for predicting ionic liquids toxicity against IPC-81 leukemia rat cell line: The predictive ability, J. Mol. Liq. 231 (2017), pp. 333–340. doi:https://doi.org/10.1016/j.molliq.2017.02.025.
- S. Ahmadi, Mathematical modeling of cytotoxicity of metal oxide nanoparticles using the index of ideality correlation criteria, Chemosphere 242 (2020), pp. 125192. doi:https://doi.org/10.1016/j.chemosphere.2019.125192.
- A. Kumar and P. Kumar, Cytotoxicity of quantum dots: Use of quasiSMILES in development of reliable models with index of ideality of correlation and the consensus modelling, J. Hazard. Mater. 402 (2021), pp. 123777. doi:https://doi.org/10.1016/j.jhazmat.2020.123777.
- S. Ahmadi, A.P. Toropova, and A.A. Toropov, Correlation intensity index: Mathematical modeling of cytotoxicity of metal oxide nanoparticles, Nanotoxicology 14 (2020), pp. 1118–1126. doi:https://doi.org/10.1080/17435390.2020.1808252.
- A.P. Toropova, A.A. Toropov, A. Roncaglioni, and E. Benfenati, The index of ideality of correlation can improve the predictive potential of models of the antioxidant capacity of tripeptides from frog skin (Litoria rubella), Comput. Biol. Med. (2021), pp. 104370. doi:https://doi.org/10.1016/j.compbiomed.2021.104370.
- P. Kumar, A. Kumar, and J. Sindhu, Design and development of novel focal adhesion kinase (FAK) inhibitors using Monte Carlo method with index of ideality of correlation to validate QSAR, SAR QSAR Environ. Res. 30 (2019), pp. 63–80. doi:https://doi.org/10.1080/1062936X.2018.1564067.
- M. Duhan, P. Kumar, J. Sindhu, R., M. Devi, A. Kumar, R. Kumar, and S. Lal, Exploring biological efficacy of novel benzothiazole linked 2,5-disubstituted-1,3,4-oxadiazole hybrids as Exploring biological efficacy of novel benzothiazole linked 2,5-disubstituted-1,3,4-oxadiazole hybrids: Exploring biological efficacy of novel benzothiazole linked 2,5-disubstituted-1,3,4-oxadiazole hybrids, molecular Exploring biological efficacy of novel benzothiazole linked 2,5-disubstituted-1,3,4-oxadiazole hybrids, molecular Exploring biological efficacy of novel benzothiazole linked 2,5-disubstituted-1,3,4-oxadiazole hybrids and Exploring biological efficacy of novel benzothiazole linked 2,5-disubstituted-1,3,4-oxadiazole hybrids, Comput. Biol. Med. 138 (2021), pp. 104876. doi:https://doi.org/10.1016/j.compbiomed.2021.104876.
- S. Ahmadi, S. Aghabeygi, M. Farahmandjou, and N. Azimi, The predictive model for band gap prediction of metal oxide nanoparticles based on quasi-SMILES, Struct. Chem. (2021), pp. 1893–1905. doi:https://doi.org/10.1007/s11224-021-01748-4.
- S. Lotfi, S. Ahmadi, and P. Zohrabi, QSAR modeling of toxicities of ionic liquids toward Staphylococcus aureus using SMILES and graph invariants, Struct. Chem. 31 (2020), pp. 2257–2270. doi:https://doi.org/10.1007/s11224-020-01568-y.
- S. Ahmadi, H. Ghanbari, S. Lotfi, and N. Azimi, Predictive QSAR modeling for the antioxidant activity of natural compounds derivatives based on Monte Carlo method, Mol. Divers. 25 (2021), pp. 87–97. doi:https://doi.org/10.1007/s11030-019-10026-9.
- S. Lotfi, S. Ahmadi, and P. Kumar, The Monte Carlo approach to model and predict the melting point of imidazolium ionic liquids using hybrid optimal descriptors, RSC Adv. 11 (2021), pp. 33849–33857. doi:https://doi.org/10.1039/D1RA06861J.
- K. Bagri, A. Kumar, M. Nimbhal, and P. Kumar, Index of ideality of correlation and correlation contradiction index: A confluent perusal on acetylcholinesterase inhibitors, Mol. Simul. 46 (2020), pp. 777–786. doi:https://doi.org/10.1080/08927022.2020.1770753.
- M. Javidfar, and S. Ahmadi, QSAR modelling of larvicidal phytocompounds against Aedes aegypti using index of ideality of correlation, SAR QSAR Environ. Res. 31 (2020), pp. 717–739. doi:https://doi.org/10.1080/1062936X.2020.1806922.
- K. Ghosh, B. Bhardwaj, S. Amin, T. Jha, and S. Gayen, Identification of structural fingerprints for ABCG2 inhibition by using Monte Carlo optimization, Bayesian classification, and structural and physicochemical interpretation (SPCI) analysis, SAR QSAR Environ. Res. 31 (2020), pp. 439–455. doi:https://doi.org/10.1080/1062936X.2020.1771769.
- M. Nimbhal, K. Bagri, P. Kumar, and A. Kumar, The index of ideality of correlation: A statistical yardstick for better QSAR modeling of glucokinase activators, Struct. Chem. 31 (2020), pp. 831–839. doi:https://doi.org/10.1007/s11224-019-01468-w.
- A. Kumar and P. Kumar, Quantitative structure toxicity analysis of ionic liquids toward acetylcholinesterase enzyme using novel QSTR models with index of ideality of correlation and correlation contradiction index, J. Mol. Liq. 318 (2020), pp. 114055. doi:https://doi.org/10.1016/j.molliq.2020.114055.
- P. Kumar and A. Kumar, In silico enhancement of azo dye adsorption affinity for cellulose fibre through mechanistic interpretation under guidance of QSPR models using Monte Carlo method with index of ideality correlation, SAR QSAR Environ. Res. 31 (2020), pp. 697–715. doi:https://doi.org/10.1080/1062936X.2020.1806105.
- K.-H. Kim, A. Maderna, M.E. Schnute, M. Hegen, S. Mohan, J. Miyashiro, L. Lin, E. Li, S. Keegan, and J. Lussier, Imidazo [1, 5-a] quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis, Bioorg. Med. Chem. Lett. 21 (2011), pp. 6258–6263. doi:https://doi.org/10.1016/j.bmcl.2011.09.008.
- B. Wang, Y. Deng, Y. Chen, K. Yu, A. Wang, Q. Liang, W. Wang, C. Chen, H. Wu, and C. Hu, Structure-activity relationship investigation for benzonaphthyridinone derivatives as novel potent Bruton’s tyrosine kinase (BTK) irreversible inhibitors, Eur. J. Med. Chem. 137 (2017), pp. 545–557. doi:https://doi.org/10.1016/j.ejmech.2017.06.016.
- C. Wang, S. Li, Q. Meng, X. Sun, H. Li, X. Shu, H. Sun, K. Liu, Z. Liu, and X. Ma, Novel amino acid-substituted diphenylpyrimidine derivatives as potent BTK inhibitors against B cell lymphoma cell lines, Bioorg. Med. Chem. 26 (2018), pp. 4179–4186. doi:https://doi.org/10.1016/j.bmc.2018.07.007.
- D. Zhao, S. Huang, M. Qu, C. Wang, Z. Liu, Z. Li, J. Peng, K. Liu, Y. Li, and X. Ma, Structural optimization of diphenylpyrimidine derivatives (DPPYs) as potent Bruton’s tyrosine kinase (BTK) inhibitors with improved activity toward B leukemia cell lines, Eur. J. Med. Chem. 126 (2017), pp. 444–455. doi:https://doi.org/10.1016/j.ejmech.2016.11.047.
- L. He, H. Pei, C. Zhang, M. Shao, D. Li, M. Tang, T. Wang, X. Chen, M. Xiang, and L. Chen, Design, synthesis and biological evaluation of 7H-pyrrolo [2, 3-d] pyrimidin-4-amine derivatives as selective Btk inhibitors with improved pharmacokinetic properties for the treatment of rheumatoid arthritis, Eur. J. Med. Chem. 145 (2018), pp. 96–112. doi:https://doi.org/10.1016/j.ejmech.2017.12.079.
- L. Liu, X. Li, Y. Cheng, L. Wang, H. Yang, J. Li, S. He, Q. Yin, and H. Xiang, Optimization of novel benzofuro [3, 2-b] pyridin-2 (1H)-one derivatives as dual inhibitors of BTK and PI3Kδ, Eur. J. Med. Chem. 164 (2019), pp. 304–316. doi:https://doi.org/10.1016/j.ejmech.2018.12.055.
- M. Xin, X. Zhao, W. Huang, Q. Jin, G. Wu, Y. Wang, F. Tang, and H. Xiang, Synthesis and biological evaluation of novel 7-substituted 3-(4-phenoxyphenyl) thieno [3, 2-c] pyridin-4-amines as potent Bruton’s tyrosine kinase (BTK) inhibitors, Bioorg. Med. Chem. 23 (2015), pp. 6250–6257. doi:https://doi.org/10.1016/j.bmc.2015.08.039.
- Q. Shi, A. Tebben, A.J. Dyckman, H. Li, C. Liu, J. Lin, S. Spergel, J.R. Burke, K.W. McIntyre, and G.C. Olini, Purine derivatives as potent Bruton’s tyrosine kinase (BTK) inhibitors for autoimmune diseases, Bioorg. Med. Chem. Lett. 24 (2014), pp. 2206–2211. doi:https://doi.org/10.1016/j.bmcl.2014.02.075.
- W.B. Young, J. Barbosa, P. Blomgren, M.C. Bremer, J.J. Crawford, D. Dambach, C. Eigenbrot, S. Gallion, A.R. Johnson, and J.E. Kropf, Discovery of highly potent and selective Bruton’s tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability, Bioorg. Med. Chem. Lett. 26 (2016), pp. 575–579. doi:https://doi.org/10.1016/j.bmcl.2015.11.076.
- X. Zhao, W. Huang, Y. Wang, M. Xin, Q. Jin, J. Cai, F. Tang, Y. Zhao, and H. Xiang, Pyrrolo [2, 3-b] pyridine derivatives as potent Bruton’s tyrosine kinase inhibitors, Bioorg. Med. Chem. 23 (2015), pp. 4344–4353. doi:https://doi.org/10.1016/j.bmc.2015.06.023.
- Y. Ge, H. Yang, C. Wang, Q. Meng, L. Li, H. Sun, Y. Zhen, K. Liu, Y. Li, and X. Ma, Design and synthesis of phosphoryl-substituted diphenylpyrimidines (Pho-DPPYs) as potent Bruton’s tyrosine kinase (BTK) inhibitors: Targeted treatment of B lymphoblastic leukemia cell lines, Bioorg. Med. Chem. 25 (2017), pp. 765–772. doi:https://doi.org/10.1016/j.bmc.2016.11.054.
- X. Zhao, M. Xin, W. Huang, Y. Ren, Q. Jin, F. Tang, H. Jiang, Y. Wang, J. Yang, and S. Mo, Design, synthesis and evaluation of novel 5-phenylpyridin-2 (1H)-one derivatives as potent reversible Bruton’s tyrosine kinase inhibitors, Bioorg. Med. Chem. 23 (2015), pp. 348–364. doi:https://doi.org/10.1016/j.bmc.2014.11.006.
- S. Ahmadi, S. Lotfi, and P. Kumar, A Monte Carlo method based QSPR model for prediction of reaction rate constants of hydrated electrons with organic contaminants, SAR QSAR Environ. Res. 31 (2020), pp. 935–950. doi:https://doi.org/10.1080/1062936X.2020.1842495.
- A.A. Toropov and A.P. Toropova, The Monte Carlo method as a tool to build up predictive QSPR/QSAR, Curr. Comput. Aided Drug Des. 16 (2020), pp. 197–206. doi:https://doi.org/10.2174/1573409915666190328123112.
- A.A. Toropov, A.P. Toropova, and E. Benfenati, Additive SMILES-based carcinogenicity models: Probabilistic principles in the search for robust predictions, Int. J. Mol. Sci. 10 (2009), pp. 3106–3127. doi:https://doi.org/10.3390/ijms10073106.
- A. Kumar and S. Chauhan, Monte Carlo method based QSAR modelling of natural lipase inhibitors using hybrid optimal descriptors, SAR QSAR Environ. Res. 28 (2017), pp. 179–197. doi:https://doi.org/10.1080/1062936X.2017.1293729.
- A.P. Toropova, A.A. Toropov, J.B. Veselinović, F.N. Miljković, and A.M. Veselinović, QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method, Eur. J. Med. Chem. 77 (2014), pp. 298–305. doi:https://doi.org/10.1016/j.ejmech.2014.03.013.
- S.C. Manisha, P. Kumar, and A. Kumar, Development of prediction model for fructose-1, 6-bisphosphatase inhibitors using the Monte Carlo method, SAR QSAR Environ. Res. 30 (2019), pp. 145–159. doi:https://doi.org/10.1080/1062936X.2019.1568299.
- A. Kumar and P. Kumar, Prediction of power conversion efficiency of phenothiazine-based dye-sensitized solar cells using Monte Carlo method with index of ideality of correlation, SAR QSAR Environ. Res. 32 (2021), pp. 817–834. doi:https://doi.org/10.1080/1062936X.2021.1973095.
- P. Kumar and A. Kumar, CORAL: QSAR models of CB1 cannabinoid receptor inhibitors based on local and global SMILES attributes with the index of ideality of correlation and the correlation contradiction index, Chemom. Intell. Lab. Syst. 200 (2020), pp. 103982. doi:https://doi.org/10.1016/j.chemolab.2020.103982.
- A.P. Toropova and A.A. Toropov, The index of ideality of correlation: A criterion of predictability of QSAR models for skin permeability? Sci. Total Environ. 586 (2017), pp. 466–472. doi:https://doi.org/10.1016/j.scitotenv.2017.01.198.
- A. Toropov, A. Toropova, G. Selvestrel, D. Baderna, and E. Benfenati, Prediction of no observed adverse effect concentration for inhalation toxicity using Monte Carlo approach, SAR QSAR Environ. Res. 31 (2020), pp. 1–12. doi:https://doi.org/10.1080/1062936X.2020.1841827.
- A.A. Toropov and A.P. Toropova, Predicting cytotoxicity of 2-phenylindole derivatives against breast cancer cells using index of ideality of correlation, Anticancer Res. 38 (2018), pp. 6189–6194. doi:https://doi.org/10.21873/anticanres.12972.
- A. Kumar and P. Kumar, Identification of good and bad fragments of tricyclic triazinone analogues as potential PKC-θ inhibitors through SMILES–based QSAR and molecular docking, Struct. Chem. 32 (2021), pp. 149–165. doi:https://doi.org/10.1007/s11224-020-01629-2.
- S. Ahmadi, Z. Moradi, A. Kumar, and A. Almasirad, SMILES-based QSAR and molecular docking study of xanthone derivatives as α-glucosidase inhibitors, J. Recept. Signal Transduct. (2021), pp. 1–12. doi:https://doi.org/10.1080/10799893.2021.1957932.
- S. Ahmadi and A. Akbari, Prediction of the adsorption coefficients of some aromatic compounds on multi-wall carbon nanotubes by the Monte Carlo method, SAR QSAR Environ. Res. 29 (2018), pp. 895–909. doi:https://doi.org/10.1080/1062936X.2018.1526821.
- A.A. Toropov, A.P. Toropova, and E. Benfenati, The QSAR-search of effective agents towards coronaviruses applying the Monte Carlo method, SAR QSAR Environ. Res. 32 (2021), pp. 689–698. doi:https://doi.org/10.1080/1062936X.2021.1952649.
- N. Chirico and P. Gramatica, Real external predictivity of QSAR models: How to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient, J. Chem. Inf. Model. 51 (2011), pp. 2320–2335. doi:https://doi.org/10.1021/ci200211n.
- G. Schüürmann, R.-U. Ebert, J. Chen, B. Wang, and R. Kühne, External validation and prediction employing the predictive squared correlation coefficient-test set activity mean vs training set activity mean, J. Chem. Inf. Model. 48 (2008), pp. 2140–2145. doi:https://doi.org/10.1021/ci800253u.
- V. Consonni, R. Todeschini, and M. Pavan, Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors. 1. Theory of the novel 3D molecular descriptors, J. Chem. Inf. Comput. Sci. 42 (2002), pp. 682–692. doi:https://doi.org/10.1021/ci015504a.
- V. Consonni, D. Ballabio, and R. Todeschini, Comments on the definition of the Q2 parameter for QSAR validation, J. Chem. Inf. Model. 49 (2009), pp. 1669–1678. doi:https://doi.org/10.1021/ci900115y.
- I. Lawrence, and K. Lin, Assay validation using the concordance correlation coefficient, Biometrics. 48 (1992), pp. 599–604.
- I. Kuzmanovski, A. Wagner, and M. Novič, Development of models for prediction of the antioxidant activity of derivatives of natural compounds, Anal. Chim. Acta 868 (2015), pp. 23–35. doi:https://doi.org/10.1016/j.aca.2015.01.050.
- T. Ghiasi, S. Ahmadi, E. Ahmadi, M. Talei Bavil Olyai, and Z. Khodadadi, The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors, SAR QSAR Environ. Res. 32 (2021), pp. 495–520. doi:https://doi.org/10.1080/1062936X.2021.1925344.
- C.R. Smith, D.R. Dougan, M. Komandla, T. Kanouni, B. Knight, J.D. Lawson, M. Sabat, E.R. Taylor, P. Vu, and C. Wyrick, Fragment-based discovery of a small molecule inhibitor of Bruton’s tyrosine kinase, J. Med. Chem. 58 (2015), pp. 5437–5444. doi:https://doi.org/10.1021/acs.jmedchem.5b00734.
- J.D. Lawson, M. Sabat, C. Smith, H. Wang, Y.K. Chen, and T. Kanouni, Cinnoline derivatives, Google Patents, 2016.
- N. Ruslin, M. Arba, and T.D. Mukhsar, QSAR, molecular docking and dynamics studies of pyrrolo [2, 3-b] pyridine derivatives as Bruton’s tyrosine kinase inhibitors, J. App. Pharm. Sci. 7 (2017), pp. 1–7.
- A. Xu, Y. Zhang, T. Ran, H. Liu, S. Lu, J. Xu, X. Xiong, Y. Jiang, T. Lu, and Y. Chen, Quantitative structure–activity relationship study on BTK inhibitors by modified multivariate adaptive regression spline and CoMSIA methods, SAR QSAR Environ. Res. 26 (2015), pp. 279–300. doi:https://doi.org/10.1080/1062936X.2015.1032346.
- L. Santos-Garcia, L.C. Assis, D.R. Silva, T.C. Ramalho, and E.F. da Cunha, QSAR analysis of nicotinamidic compounds and design of potential Bruton’s tyrosine kinase (BTK) inhibitors, J. Biomol. Struct. Dyn. 34 (2016), pp. 1421–1440. doi:https://doi.org/10.1080/07391102.2015.1070750.
- P.K. Balasubramanian, A. Balupuri, H.Y. Kang, and S.J. Cho, Receptor-guided 3D-QSAR studies, molecular dynamics simulation and free energy calculations of BTK kinase inhibitors, BMC Syst. Biol. 11 (2017), pp. 6–17. doi:https://doi.org/10.1186/s12918-017-0385-5.